Characteristics of Myocardial Tissue Staining and Lesion Creation with an Infusion-Needle Ablation Catheter for Treatment of Ventricular Tachycardia in Humans.

08:00 EDT 8th October 2019 | BioPortfolio

Summary of "Characteristics of Myocardial Tissue Staining and Lesion Creation with an Infusion-Needle Ablation Catheter for Treatment of Ventricular Tachycardia in Humans."

Intramural substrate causing ventricular tachycardia (VT) can be targeted by radiofrequency infusion-needle catheter ablation (RFA).


Journal Details

This article was published in the following journal.

Name: Heart rhythm
ISSN: 1556-3871


DeepDyve research library

PubMed Articles [15499 Associated PubMed Articles listed on BioPortfolio]

Culprit lesion morphology in young patients with ST-segment elevated myocardial infarction: A clinical, angiographic and optical coherence tomography study.

About 20% of patients with ST-segment elevated myocardial infarction (STEMI) are young adults. Morphological characteristics of culprit lesion in young STEMI patients have not been systematically eval...

Transient depression of myocardial function after influenza virus infection: A study of echocardiographic tissue imaging.

Influenza virus infection (IVI) was reported to be associated with minor cardiac changes, mostly those detected on electrocardiogram with and without elevated blood markers of myocardial injury; howev...

Vasoactive intestinal peptide infusion reverses existing myocardial fibrosis in the rat.

Congestive cardiac failure has become one of the major health challenges of the 21st century and new therapies are needed to address this problem. The concentration of vasoactive intestinal peptide (V...

Moving the Needle: Tissue Characterization and Lesion Formation During Infusion-Needle Ablation.

Sequence and time course of depletion of cardiac cellular proteins and accumulation of plasma proteins in rat early ischemic myocardium.

In order to investigate the sequence and time course of fibronectin (Fn), fibrinogen (Fg), complement (C5), myoglobin (Mb), actin (HHF35), and desmin (Dm) for the diagnosis of early myocardial ischemi...

Clinical Trials [11315 Associated Clinical Trials listed on BioPortfolio]

LTX-315 and Adoptive T-cell Therapy in Advanced Soft Tissue Sarcoma

This is a two part, single arm study designed to determine the safety and effectiveness of LTX-315 to induce T-cell infiltration prior to TIL expansion in patients with soft tissue sarcoma...

Effects Of Losartan On Myocardial Structure In Diabetic Hypertensive Patients With Left Ventricular

The anthypertensive treatment with Losartan may have benefits beyond blood pressure reduction on myocardial structure and function in hypertensive diabetic patients. We will evaluate the e...

Myocardial Regeneration and Angiogenesis in Myocardial Infarction With G-CSF and Intra-Coronary Stem Cell Infusion-3-DES

This trial was performed to evaluate the safety of G-CSF based stem cell therapy and to compare outcome of intracoronary infusion of mobilized PBSCs between patients with AMI and OMI.

The INFUSE - Anterior Myocardial Infarction (AMI) Study

This is a multicenter, open-label, controlled, single-blind, randomized study with up to 452 subjects enrolled in up to 40 US and European sites. Subjects who present with anterior ST-elev...

Which One Should be Treated in the Setting of Acute ST Elevation Myocardial Infarction - Culprit Lesion or Culprit Vessel?

The current guidelines still recommend emergent PCI of the culprit lesion and state that primary PCI should be limited to the culprit vessel with the exception of cardiogenic shock and per...

Medical and Biotech [MESH] Definitions

A method for removing lesions from gastrointestinal MUCOUS MEMBRANES. The mucosal tissue with the lesion is elevated by injecting a solution into the submucosal layer underneath it. The elevated tissue with the lesion is then cut out.

Exposure of myocardial tissue to brief, repeated periods of vascular occlusion in order to render the myocardium resistant to the deleterious effects of ISCHEMIA or REPERFUSION. The period of pre-exposure and the number of times the tissue is exposed to ischemia and reperfusion vary, the average being 3 to 5 minutes.

A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).

Beverages used in TRADITIONAL MEDICINE that are prepared from the infusion of plant tissue (HERBAL TEA), and/or animal tissue or other organisms such as FUNGI.

The creation and display of functional images showing where the blood is flowing into the MYOCARDIUM by following over time the distribution of tracers injected into the blood stream.

Quick Search

DeepDyve research library

Searches Linking to this Article